{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:47:25Z","timestamp":1786985245457,"version":"build-2736575974"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,27]],"date-time":"2023-06-27T00:00:00Z","timestamp":1687824000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003407","name":"MIUR","doi-asserted-by":"publisher","award":["2017T9JNLT"],"award-info":[{"award-number":["2017T9JNLT"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.biopha.2023.115094","type":"journal-article","created":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T17:30:40Z","timestamp":1688059840000},"page":"115094","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Advances in peripheral blood biomarkers of patients with Alzheimer\u2019s disease: Moving closer to personalized therapies"],"prefix":"10.1016","volume":"165","author":[{"given":"Gabriella","family":"Ferretti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Serafini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Angiolillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Monterosso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Di Costanzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6719-0107","authenticated-orcid":false,"given":"Carmela","family":"Matrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.biopha.2023.115094_bib1","doi-asserted-by":"crossref","first-page":"507","DOI":"10.14283\/jpad.2022.41","article-title":"Clinical trial endpoints and their clinical meaningfulness in early stages of Alzheimer's disease","volume":"9","author":"Cohen","year":"2022","journal-title":"J. Prev. Alzheimers Dis."},{"key":"10.1016\/j.biopha.2023.115094_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.742408","article-title":"Alzheimer's disease: an update and insights into pathophysiology","volume":"14","author":"Abubakar","year":"2022","journal-title":"Front. Aging Neurosci."},{"issue":"1","key":"10.1016\/j.biopha.2023.115094_bib3","doi-asserted-by":"crossref","first-page":"15612","DOI":"10.1038\/s41598-020-71832-y","article-title":"Blood biomarkers indicate that the preclinical stages of Alzheimer's disease present overlapping molecular features","volume":"10","author":"Di Costanzo","year":"2020","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.biopha.2023.115094_bib4","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s11011-022-01114-1","article-title":"Blood-based biomarkers in Alzheimer's disease: a mini-review","volume":"38","author":"Padala","year":"2023","journal-title":"Metab. Brain Dis."},{"issue":"2","key":"10.1016\/j.biopha.2023.115094_bib5","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/alz.12395","article-title":"Detecting amyloid positivity in early Alzheimer's disease using combinations of plasma A\u00ce\u00b242\/A\u00ce\u00b240 and p-tau","volume":"18","author":"Janelidze","year":"2022","journal-title":"Alzheimers Dement"},{"issue":"2","key":"10.1016\/j.biopha.2023.115094_bib6","article-title":"Plasma and cerebrospinal fluid ABeta42 for the differential diagnosis of Alzheimer's disease dementia in participants diagnosed with any dementia subtype in a specialist care setting","volume":"2","author":"Kokkinou","year":"2021","journal-title":"Cochrane Database Syst. Rev."},{"issue":"12","key":"10.1016\/j.biopha.2023.115094_bib7","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1002\/alz.12756","article-title":"The Alzheimer's Association appropriate use recommendations for blood biomarkers in Alzheimer's disease","volume":"18","author":"Hansson","year":"2022","journal-title":"Alzheimers Dement"},{"issue":"9","key":"10.1016\/j.biopha.2023.115094_bib8","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1038\/nm1635","article-title":"Clearance of amyloid-beta by circulating lipoprotein receptors","volume":"13","author":"Sagare","year":"2007","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.biopha.2023.115094_bib9","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3233\/JAD-2010-101248","article-title":"Impaired lipoprotein receptor-mediated peripheral binding of plasma amyloid-\u03b2 is an early biomarker for mild cognitive impairment preceding Alzheimer's disease","volume":"24","author":"Sagare","year":"2011","journal-title":"J. Alzheimers Dis."},{"issue":"5","key":"10.1016\/j.biopha.2023.115094_bib10","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1001\/archneur.57.5.646","article-title":"Role of the low-density lipoprotein receptor-related protein in beta-amyloid metabolism and Alzheimer disease","volume":"57","author":"Hyman","year":"2000","journal-title":"Arch. Neurol."},{"issue":"8","key":"10.1016\/j.biopha.2023.115094_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/cells9081807","article-title":"Fyn tyrosine kinase elicits amyloid precursor protein Tyr682 phosphorylation in neurons from Alzheimer's disease patients","volume":"9","author":"Iannuzzi","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.biopha.2023.115094_bib12","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.arr.2019.04.003","article-title":"The Y","volume":"52","author":"Matrone","year":"2019","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.biopha.2023.115094_bib13","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3389\/fnmol.2017.00059","article-title":"An aberrant phosphorylation of amyloid precursor protein tyrosine regulates its trafficking and the binding to the clathrin endocytic complex in neural stem cells of Alzheimer's disease patients","volume":"10","author":"Poulsen","year":"2017","journal-title":"Front. Mol. Neurosci."},{"issue":"12","key":"10.1016\/j.biopha.2023.115094_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21124444","article-title":"Fyn tyrosine kinase as harmonizing factor in neuronal functions and dysfunctions","volume":"21","author":"Matrone","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2023.115094_bib15","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1186\/s12974-018-1376-1","article-title":"Circulating levels of IL-1 family cytokines and receptors in Alzheimer's disease: new markers of disease progression?","volume":"15","author":"Italiani","year":"2018","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.biopha.2023.115094_bib16","first-page":"1","article-title":"Death by TNF: a road to inflammation","author":"van Loo","year":"2022","journal-title":"Nat. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.biopha.2023.115094_bib17","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.cellimm.2012.01.001","article-title":"Aging is associated with circulating cytokine dysregulation","volume":"273","author":"Alvarez-Rodr\u00edguez","year":"2012","journal-title":"Cell Immunol."},{"issue":"2\u20133","key":"10.1016\/j.biopha.2023.115094_bib18","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0169-409X(98)00086-6","article-title":"Penetration of neurotrophins and cytokines across the blood-brain\/blood-spinal cord barrier","volume":"36","author":"Pan","year":"1999","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.biopha.2023.115094_bib19","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.1600-065X.2012.01127.x","article-title":"Inflammatory cell trafficking across the blood-brain barrier: chemokine regulation and in vitro models","volume":"248","author":"Takeshita","year":"2012","journal-title":"Immunol. Rev."},{"issue":"9","key":"10.1016\/j.biopha.2023.115094_bib20","doi-asserted-by":"crossref","first-page":"3649","DOI":"10.1523\/JNEUROSCI.19-09-03649.1999","article-title":"Upregulation of tumor necrosis factor alpha transport across the blood-brain barrier after acute compressive spinal cord injury","volume":"19","author":"Pan","year":"1999","journal-title":"J. Neurosci."},{"issue":"4","key":"10.1016\/j.biopha.2023.115094_bib21","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1159\/000097202","article-title":"Passage of cytokines across the blood-brain barrier","volume":"2","author":"Banks","year":"1995","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.biopha.2023.115094_bib22","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.exger.2017.12.019","article-title":"Role of the peripheral innate immune system in the development of Alzheimer's disease","volume":"107","author":"Le Page","year":"2018","journal-title":"Exp. Gerontol."},{"issue":"9","key":"10.1016\/j.biopha.2023.115094_bib23","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s11306-021-01828-w","article-title":"Challenges in LC-MS-based metabolomics for Alzheimer's disease early detection: targeted approaches versus untargeted approaches","volume":"17","author":"Reveglia","year":"2021","journal-title":"Metabolomics"},{"issue":"5","key":"10.1016\/j.biopha.2023.115094_bib24","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/ana.26464","article-title":"Association between human blood metabolome and the risk of Alzheimer's disease","volume":"92","author":"Sun","year":"2022","journal-title":"Ann. Neurol."},{"issue":"7","key":"10.1016\/j.biopha.2023.115094_bib25","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1080\/14737159.2022.2104639","article-title":"Alzheimer's disease: a scoping review of biomarker research and development for effective disease diagnosis","volume":"22","author":"Faldu","year":"2022","journal-title":"Expert Rev. Mol. Diagn."},{"issue":"11","key":"10.1016\/j.biopha.2023.115094_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23116235","article-title":"Lipidomics of bioactive lipids in Alzheimer's and Parkinson's diseases: where are we?","volume":"23","author":"Chiurchi\u00f9","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2023.115094_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s43657-021-00036-9","article-title":"Recent advances in understanding of Alzheimer's disease progression through mass spectrometry-based metabolomics","volume":"2","author":"Mill","year":"2022","journal-title":"Phenomics"},{"key":"10.1016\/j.biopha.2023.115094_bib28","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1471-2296-9-29","article-title":"The accuracy of the MMSE in detecting cognitive impairment when administered by general practitioners: a prospective observational study","volume":"9","author":"Pezzotti","year":"2008","journal-title":"BMC Fam. Pr."},{"issue":"3","key":"10.1016\/j.biopha.2023.115094_bib29","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1080\/07317115.2020.1756021","article-title":"Trajectories of mini-mental state examination scores over the lifespan in general populations: a systematic review and meta-regression analysis","volume":"45","author":"Nagaratnam","year":"2022","journal-title":"Clin. Gerontol."},{"issue":"3","key":"10.1016\/j.biopha.2023.115094_bib30","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimers Dement"},{"issue":"10","key":"10.1016\/j.biopha.2023.115094_bib31","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1002\/(SICI)1099-1166(199910)14:10<858::AID-GPS35>3.0.CO;2-8","article-title":"Short versions of the geriatric depression scale: a study of their validity for the diagnosis of a major depressive episode according to ICD-10 and DSM-IV","volume":"14","author":"Almeida","year":"1999","journal-title":"Int. J. Geriatr. Psychiatry"},{"issue":"4","key":"10.1016\/j.biopha.2023.115094_bib32","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1194\/jlr.R600021-JLR200","article-title":"The role of TNF-alpha in chronic inflammatory conditions, intermediary metabolism, and cardiovascular risk","volume":"48","author":"Popa","year":"2007","journal-title":"J. Lipid Res"},{"issue":"3","key":"10.1016\/j.biopha.2023.115094_bib33","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S1474-4422(04)00683-0","article-title":"Is Alzheimer's disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics","volume":"3","author":"de la Torre","year":"2004","journal-title":"Lancet Neurol."},{"issue":"7","key":"10.1016\/j.biopha.2023.115094_bib34","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1161\/STROKEAHA.108.536839","article-title":"Beta-amyloid, blood vessels, and brain function","volume":"40","author":"Smith","year":"2009","journal-title":"Stroke"},{"issue":"10","key":"10.1016\/j.biopha.2023.115094_bib35","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/nrn2233","article-title":"A neuroscientist's guide to lipidomics","volume":"8","author":"Piomelli","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"issue":"23","key":"10.1016\/j.biopha.2023.115094_bib36","doi-asserted-by":"crossref","first-page":"17221","DOI":"10.1074\/jbc.R000005200","article-title":"Structure and function of sphingolipid- and cholesterol-rich membrane rafts","volume":"275","author":"Brown","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.biopha.2023.115094_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002482","article-title":"Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: a targeted metabolomics study","volume":"15","author":"Varma","year":"2018","journal-title":"PLoS Med"},{"issue":"9","key":"10.1016\/j.biopha.2023.115094_bib38","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.jalz.2017.01.020","article-title":"Metabolic network failures in Alzheimer's disease: a biochemical road map","volume":"13","author":"Toledo","year":"2017","journal-title":"Alzheimers Dement"},{"issue":"3","key":"10.1016\/j.biopha.2023.115094_bib39","doi-asserted-by":"crossref","first-page":"fcab139","DOI":"10.1093\/braincomms\/fcab139","article-title":"Serum metabolites associated with brain amyloid beta deposition, cognition and dementia progression","volume":"3","author":"Nho","year":"2021","journal-title":"Brain Commun."},{"issue":"4","key":"10.1016\/j.biopha.2023.115094_bib40","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nm.3466","article-title":"Plasma phospholipids identify antecedent memory impairment in older adults","volume":"20","author":"Mapstone","year":"2014","journal-title":"Nat. Med"},{"issue":"5","key":"10.1016\/j.biopha.2023.115094_bib41","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1073\/pnas.89.5.1671","article-title":"Evidence for a membrane defect in Alzheimer disease brain","volume":"89","author":"Nitsch","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"10.1016\/j.biopha.2023.115094_bib42","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jalz.2016.08.003","article-title":"Association of blood lipids with Alzheimer's disease: a comprehensive lipidomics analysis","volume":"13","author":"Proitsi","year":"2017","journal-title":"Alzheimers Dement"},{"issue":"6","key":"10.1016\/j.biopha.2023.115094_bib43","doi-asserted-by":"crossref","first-page":"641","DOI":"10.2174\/1567205013666160129095138","article-title":"Metabolomic-driven elucidation of serum disturbances associated with Alzheimer's disease and mild cognitive impairment","volume":"13","author":"Gonz\u00e1lez-Dom\u00ednguez","year":"2016","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.biopha.2023.115094_bib44","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jprot.2014.01.014","article-title":"Combination of metabolomic and phospholipid-profiling approaches for the study of Alzheimer's disease","volume":"104","author":"Gonz\u00e1lez-Dom\u00ednguez","year":"2014","journal-title":"J. Proteom."},{"issue":"5","key":"10.1016\/j.biopha.2023.115094_bib45","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20051149","article-title":"An updated review of lysophosphatidylcholine metabolism in human diseases","volume":"20","author":"Law","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2023.115094_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamem.2020.183481","article-title":"Phospholipase A2 way to hydrolysis: Dint formation, hydrophobic mismatch, and lipid exclusion","volume":"1863","author":"Alekseeva","year":"2021","journal-title":"Biochim Biophys. Acta Biomembr."},{"key":"10.1016\/j.biopha.2023.115094_bib47","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3389\/fpls.2020.00403","article-title":"Functional characterization of Lysophosphatidylcholine: Acyl-CoA acyltransferase genes from sunflower","volume":"11","author":"Mapelli-Brahm","year":"2020","journal-title":"Front. Plant Sci."},{"issue":"7","key":"10.1016\/j.biopha.2023.115094_bib48","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.jalz.2015.12.008","article-title":"Blood metabolite markers of preclinical Alzheimer's disease in two longitudinally followed cohorts of older individuals","volume":"12","author":"Casanova","year":"2016","journal-title":"Alzheimers Dement"},{"issue":"3","key":"10.1016\/j.biopha.2023.115094_bib49","first-page":"295","article-title":"The ratio of phosphatidylcholines to lysophosphatidylcholines in plasma differentiates healthy controls from patients with Alzheimer's disease and mild cognitive impairment","volume":"1","author":"Klavins","year":"2015","journal-title":"Alzheimers Dement"},{"issue":"10","key":"10.1016\/j.biopha.2023.115094_bib50","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1097\/NEN.0000000000000116","article-title":"Lysophosphatidylcholine and amide as metabolites for detecting alzheimer disease using ultrahigh-performance liquid chromatography-quadrupole time-of-flight mass spectrometry-based metabonomics","volume":"73","author":"Cui","year":"2014","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"8","key":"10.1016\/j.biopha.2023.115094_bib51","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s00702-003-0007-9","article-title":"Decreased lysophosphatidylcholine\/phosphatidylcholine ratio in cerebrospinal fluid in Alzheimer's disease","volume":"110","author":"Mulder","year":"2003","journal-title":"J. Neural Transm."},{"issue":"10","key":"10.1016\/j.biopha.2023.115094_bib52","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1002\/bies.201300041","article-title":"A new molecular explanation for age-related neurodegeneration: the Tyr682 residue of amyloid precursor protein","volume":"35","author":"Matrone","year":"2013","journal-title":"Bioessays"},{"issue":"1","key":"10.1016\/j.biopha.2023.115094_bib53","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci11010103","article-title":"Might fibroblasts from patients with Alzheimer's disease reflect the brain pathology? A focus on the increased phosphorylation of amyloid precursor protein Tyr","volume":"11","author":"Iannuzzi","year":"2021","journal-title":"Brain Sci."},{"issue":"3","key":"10.1016\/j.biopha.2023.115094_bib54","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/jnc.13429","article-title":"An isoform-specific role of FynT tyrosine kinase in Alzheimer's disease","volume":"136","author":"Lee","year":"2016","journal-title":"J. Neurochem"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223008855?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223008855?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T07:13:46Z","timestamp":1777878826000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332223008855"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":54,"alternative-id":["S0753332223008855"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115094","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advances in peripheral blood biomarkers of patients with Alzheimer\u2019s disease: Moving closer to personalized therapies","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115094","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"115094"}}